Evercore ISI Group Downgrades Twist Bioscience to In-Line, Raises Price Target to $102

Benzinga Newsdesk www.benzinga.com Negative 55.2%

Neg 55.2% Neu 0% Pos 0%

Evercore ISI Group analyst Vijay Kumar downgrades Twist Bioscience (NASDAQ:TWST) from Outperform to In-Line and raises the price target from $66 to $102.